Cargando…
Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamics
Antibody–drug conjugates are powerful tools for combatting a wide array of cancers. Drug conjugation to a therapeutic antibody often alters molecular characteristics, such as hydrophobicity and effector function, resulting in quality deterioration. To develop a drug conjugation methodology that main...
Autores principales: | Kiyoshi, Masato, Nakakido, Makoto, Rafique, Abdur, Tada, Minoru, Aoyama, Michihiko, Terao, Yosuke, Nagatoishi, Satoru, Shibata, Hiroko, Ide, Teruhiko, Tsumoto, Kouhei, Ito, Yuji, Ishii-Watabe, Akiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545826/ https://www.ncbi.nlm.nih.gov/pubmed/37783706 http://dx.doi.org/10.1038/s41598-023-43431-0 |
Ejemplares similares
-
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
por: Kiyoshi, Masato, et al.
Publicado: (2018) -
Biophysical Characterization of the Contribution of
the Fab Region to the IgG-FcγRIIIa Interaction
por: Kosuge, Hirofumi, et al.
Publicado: (2022) -
Highly sensitive HPLC analysis and biophysical characterization of N‐glycans of IgG‐Fc domain in comparison between CHO and 293 cells using FcγRIIIa ligand
por: Kosuge, Hirofumi, et al.
Publicado: (2020) -
Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies
por: Aoyama, Michihiko, et al.
Publicado: (2019) -
Characterization of anti-SARS-CoV-2 monoclonal antibodies focusing on antigen binding, neutralization, and FcγR activation via formation of immune complex
por: Tada, Minoru, et al.
Publicado: (2023)